Lacosamide is a Oral Solution in the Human Prescription Drug category. It is labeled and distributed by Amneal Pharmaceuticals Of New York, Llc. The primary component is Lacosamide.
| Product ID | 65162-912_32fb4b27-d0ee-4fb9-9f4f-f3845999d299 |
| NDC | 65162-912 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Lacosamide |
| Generic Name | Lacosamide |
| Dosage Form | Solution |
| Route of Administration | ORAL |
| Marketing Start Date | 2013-11-29 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA204839 |
| Labeler Name | Amneal Pharmaceuticals of New York, LLC |
| Substance Name | LACOSAMIDE |
| Active Ingredient Strength | 10 mg/mL |
| Pharm Classes | Anti-epileptic Agent [EPC],Decreased Central Nervous System Disorganized Electrical Activity [PE] |
| DEA Schedule | CV |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |
| Marketing Start Date | 2013-11-29 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA204839 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2013-11-29 |
| Inactivation Date | 2020-01-31 |
| Ingredient | Strength |
|---|---|
| LACOSAMIDE | 10 mg/mL |
| SPL SET ID: | a2c72461-3538-4a38-8994-e5fb1637c294 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0121-0992 | Lacosamide | Lacosamide |
| 0121-1984 | Lacosamide | Lacosamide |
| 0121-2976 | Lacosamide | Lacosamide |
| 0121-3968 | Lacosamide | Lacosamide |
| 63850-0055 | Lacosamide | Lacosamide |
| 63850-0053 | Lacosamide | Lacosamide |
| 63850-0054 | Lacosamide | Lacosamide |
| 63850-0056 | Lacosamide | Lacosamide |
| 65162-912 | Lacosamide | Lacosamide |
| 0131-1810 | Vimpat | lacosamide |
| 0131-2470 | Vimpat | lacosamide |
| 0131-2477 | Vimpat | lacosamide |
| 0131-2478 | Vimpat | lacosamide |
| 0131-2479 | Vimpat | lacosamide |